Skip to content

Tonic Pain and Transauricular Vagal Nerve Stimulation

Exploration of the Effect, and Their Duration, of Different Frequency Transcutaneous Auricular Vagal Nerve Stimulation on Sensory Perception.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07325058
Enrollment
36
Registered
2026-01-08
Start date
2025-12-18
Completion date
2026-04-30
Last updated
2026-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Experimental Pain in Healthy Human Subjects

Keywords

cross-over, taVNS

Brief summary

This study aims to explore the effect of burst-taVNS (electric stimulation of the concha cymba) on tonic (capsaicin-induced skin pain) and acute (pressure pain sensitivity) experimental pain and cardioception. Primary outcomes include pain intensity. Secondary outcomes include sensory thresholds, resting heart rate (EKG), pupillary measurements and conditioned pain modulation.

Detailed description

Across 3 visits, each lasting around 2.5hours, burst-taVNS (electrical stimulation of the concha cymba) will be compared to active-control (electrircal stimulation of the earlobe) and sham (no current) stimulation, two gold-standard controls. Assessments of outcomes will occur before capsaicin application and before, twice during and after electrical ear stimulation.

Interventions

DEVICEtaVNS

Two-headed ball-point electrode which is placed in the concha cymba.

Circular urface adhering electrodes will be attached to either facet of the earlobe.

DEVICESham (No Treatment)

Circular surface adhesive electrodes will be placed on either facet of the earlobe. No current will pass through the electrodes.

Sponsors

Aalborg University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Electrodes for the different stimulation conditions will be applied during all three visits regardless of which stimulation is active. Wiring of the electrodes is the same but labelled with 'A' or 'B'. Corresponding stimulation condition will not be known to the experimenter (that is also analyzing the data) until after data analysis.

Intervention model description

Burst-taVNS, active-control (electrical stimulation of the earlobe) or sham will be administred to the participant on one of the three visits. Order of stimulation condition will be randomly selected and counter-balanced across participants (minding sex at birth).

Eligibility

Sex/Gender
ALL
Age
16 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy * Speak and understand English * 18-60 years old.

Exclusion criteria

* Pregnant and/or breastfeeding * Regular use of cannabis, opioids or other drugs * Current or previous neurologic, musculoskeletal, mental, or other illnesses (e.g., brain or spinal cord injuries, degenerative neurological disorders, major depression, cardiovascular disease, chronic lung disease, etc.) * Current regular (once or more a week) use of analgesic medication or other medication which may affect the trial (including paracetamol and NSAIDs) * Recent history of acute pain particularly in the lower limbs * Abnormally disrupted sleep in 24 hours preceding experiment * Contraindications to electric stimulation application (history of epilepsy, metal implants in head or jaw, etc.) * Lack of ability to cooperate * Contraindications for capsaicin including an intolerance chili consumption and burns or wounds to the application site.

Design outcomes

Primary

MeasureTime frameDescription
Pain IntensityFrom when capsaicin is applied to the end of the experiment in 5 min intervals.Capaisin is a topically administered tonic pain model. Stemming from its chilly-origin, pain induced ressembels heat/light burning sensation which increases within 20minute of application to the forearm, before it plateaus. Associated pain can be stopped immediately by applying ice/cold water. Participants will be asked to rate (using a scale from 0 denoting no pain, to 10 denoting maximal pain) the intensity of the pain in 5 min time intervals.

Secondary

MeasureTime frameDescription
Conditioned Pain Modulation EffectBefore Capsaicin application and at 3 time intervals from when the ear stimulation (taVNS, Active Control or Sham) is applied: before, as the stimulation starts and halfway during (at min 20).Using the computerized pressure pain algometer tool (Nocitech, Aalborg, Denmark), cuffs placed on the calves of participants wll inflate at a consistent rate. Whilst participants have a constant pressure applied to their non-dominant leg, they are instructed to rate the pain experienced on the dominant leg as the cuff slowly inflates using a visual analogue scale (VAS) and to press a button when the pain becomes intolerable. The VAS ranges from 0 denoting no pain, to 10 denoting maximal pain. Conditioned pain detection, namely the kPa where the VAS is at 1cm, will be acquired.
Pressure Pain PerceptionBefore Capsaicin application and at 3 time intervals from when the ear stimulation (taVNS, Active Control or Sham) is applied: before, as the stimulation starts and halfway during (at min 20).Trapezius pressure pain perception will be acquired using a handheld pressure algometer (Somedic, Solna, Sweden). Perpendicular to the musle and halfway between the acrominion and the processus spinous vertebrae, the 1cm2 probe will be applied at a constant rate. When particpants first feel pressure pain, they will respond with a button-press.
Pressure Pain Detection ThresholdBefore Capsaicin application and at 3 time intervals from when the ear stimulation (taVNS, Active Control or Sham) is applied: before, as the stimulation starts and halfway during (at min 20).Using the computerized pressure pain algometer tool (Nocitech, Aalborg, Denmark), cuffs placed on the calves of participants wll inflate at a consistent rate. Participants are instructed to rate the pain experiences using a visual analogue scale (VAS) and to press a button when the pain becomes intolerable. The VAS ranges from 0 denoting no pain, to 10 denoting maximal pain. Pain detection, namely the kPa where the VAS is at 1cm, and the pain tolerance, namely the kPa when the deflation-button is pressed, will be acquired.
ElectrocardiographyBefore Capsaicin application and at 3 time intervals from when the ear stimulation (taVNS, Active Control or Sham) is applied: before, as the stimulation starts and halfway during (at min 20).Using a 3-lead system (reference electrode on the clavicle, whilst the other two leads reside on the sternum and V4), resting state electrocardiography will be acquired.
Cardioception AccuracyBefore Capsaicin application and at 3 time intervals from when the ear stimulation (taVNS, Active Control or Sham) is applied: before, as the stimulation starts and halfway during (at min 20).The ability to perceive your heart beats is described as cardioception. One means by which to assess this ability is the 'heartbeat couting task'. Herein, using a queue, participants are tasked to count their heartbeats in 3 undislosed and randomized durations (25, 35 and 35s). This value is then compare to the actual number of beats during each time interval, which is acquired via electrocardiography.
Pupillary Light ReflexBefore Capsaicin application and at 3 time intervals from when the ear stimulation (taVNS, Active Control or Sham) is applied: before, as the stimulation starts and halfway during (at min 20).Using the Neurolight, per pupil, a 3s light reflex will be acquired. This refers to the reflex following the exposure to a light flash.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026